PATENT CLAIM ANALYSIS

Application Number: 15903547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "012000"]

Abstract:
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent.

Claim (Index 1):
A method for treating a bleeding episode in a subject in need of such treatment, said method comprising administering intravenously to said subject a Factor VIIa equivalent, wherein said administering is in a single dose and said dose comprises a single-dose-effective amount of said Factor VIIa equivalent and wherein, subsequent to said administration, no further Factor VIIa equivalent is administered to said subject for a period of at least 4 hours.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12127917', '10290814', '13987492', '15258908', '10255032']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7500232581906682
- 35 USC 102 Novelty (BERT): 0.6410072469691387
- Combined Prediction Score: 0.7391216570685152
- Mean Citation Score: 463.86342
- Max Citation Score: 646.3531
- Similarity Product: 564.9062224641502

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test